276 related articles for article (PubMed ID: 9257301)
1. Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage.
Ikeda K; Asakura H; Futami K; Yamashita J
Neurosurgery; 1997 Aug; 41(2):344-9; discussion 349-50. PubMed ID: 9257301
[TBL] [Abstract][Full Text] [Related]
2. Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage.
Suzuki M; Kudo A; Otawara Y; Hirashima Y; Takaku A; Ogawa A
Neurosurgery; 1999 Mar; 44(3):487-93; discussion 493-4. PubMed ID: 10069585
[TBL] [Abstract][Full Text] [Related]
3. Changes in the coagulation and fibrinolytic system of patients with subarachnoid hemorrhage.
Ji Y; Meng QH; Wang ZG
Neurol Med Chir (Tokyo); 2014 Jun; 54(6):457-64. PubMed ID: 24305025
[TBL] [Abstract][Full Text] [Related]
4. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T
Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.
Kramer AH; Jenne C; Holodinsky JK; Todd S; Roberts DJ; Kubes P; Zygun DA; Hill MD; Leger C; Wong JH
Neurocrit Care; 2015 Dec; 23(3):386-93. PubMed ID: 25739904
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic activity in the CSF and blood following subarachnoid haemorrhage.
Suzuki M; Kudo A; Otawara Y; Doi M; Kuroda K; Ogawa A
Acta Neurochir (Wien); 1997; 139(12):1152-4. PubMed ID: 9479421
[TBL] [Abstract][Full Text] [Related]
8. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
Usui M; Saito N; Hoya K; Todo T
Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
[TBL] [Abstract][Full Text] [Related]
9. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
10. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma.
Seifert V; Löffler BM; Zimmermann M; Roux S; Stolke D
J Neurosurg; 1995 Jan; 82(1):55-62. PubMed ID: 7815135
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y in the primate model of subarachnoid hemorrhage.
Pluta RM; Deka-Starosta A; Zauner A; Morgan JK; Muraszko KM; Oldfield EH
J Neurosurg; 1992 Sep; 77(3):417-23. PubMed ID: 1506889
[TBL] [Abstract][Full Text] [Related]
12. [Fibrinolytic activity of cerebrospinal fluid as an indicator of the risk of repeated ruptures of arterial aneurysms].
Kholodov SA; Shelkovskiĭ VN; Platonova TK
Zh Vopr Neirokhir Im N N Burdenko; 1985; (4):18-22. PubMed ID: 4050242
[TBL] [Abstract][Full Text] [Related]
13. A study of blood coagulation and fibrinolytic system in spontaneous subarachnoid hemorrhage. Correlation with hunt-hess grade and outcome.
Nina P; Schisano G; Chiappetta F; Luisa Papa M; Maddaloni E; Brunori A; Capasso F; Corpetti MG; Demurtas F
Surg Neurol; 2001 Apr; 55(4):197-203. PubMed ID: 11358585
[TBL] [Abstract][Full Text] [Related]
14. Effect of intrathecal fibrinolysis on cerebrospinal fluid absorption after experimental subarachnoid hemorrhage.
Brinker T; Seifert V; Stolke D
J Neurosurg; 1991 May; 74(5):789-93. PubMed ID: 1901600
[TBL] [Abstract][Full Text] [Related]
15. Activated complement components C3a and C4a in cerebrospinal fluid and plasma following subarachnoid hemorrhage.
Kasuya H; Shimizu T
J Neurosurg; 1989 Nov; 71(5 Pt 1):741-6. PubMed ID: 2809729
[TBL] [Abstract][Full Text] [Related]
16. Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage.
Roos YB; Levi M; Carroll TA; Beenen LF; Vermeulen M
Stroke; 2001 Aug; 32(8):1860-2. PubMed ID: 11486117
[TBL] [Abstract][Full Text] [Related]
17. Hemostasis and fibrinolysis activation after subarachnoid hemorrhage.
Peltonen S; Juvela S; Kaste M; Lassila R
J Neurosurg; 1997 Aug; 87(2):207-14. PubMed ID: 9254083
[TBL] [Abstract][Full Text] [Related]
18. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.
Mizoi K; Yoshimoto T; Takahashi A; Fujiwara S; Koshu K; Sugawara T
J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145
[TBL] [Abstract][Full Text] [Related]
19. Cisternal CSF levels of cytokines after subarachnoid hemorrhage.
Gaetani P; Tartara F; Pignatti P; Tancioni F; Rodriguez y Baena R; De Benedetti F
Neurol Res; 1998 Jun; 20(4):337-42. PubMed ID: 9618698
[TBL] [Abstract][Full Text] [Related]
20. Changes of endothelin concentration in cerebrospinal fluid and plasma of patients with aneurysmal subarachnoid hemorrhage.
Shirakami G; Magaribuchi T; Shingu K; Kim S; Saito Y; Nakao K; Mori K
Acta Anaesthesiol Scand; 1994 Jul; 38(5):457-61. PubMed ID: 7941940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
